Literature DB >> 3928321

Use of temocillin in typhoid fever, hepatobiliary disease and other infections.

D Tanphaichitra, S Kanjanapanjapol, S Srimuang, O P Robinson.   

Abstract

During 1980-1984, 51 patients with enteric fever (typhoid/paratyphoid fever and salmonellosis) biliary tract sepsis, and other Gram-negative infections were treated with temocillin at 3 medical centres in Bangkok, Thailand. This article summarises the results in the 42 evaluable patients (14 males, 28 females); 10 patients with enteric fever, 2 patients with salmonellosis; 12 patients with biliary tract sepsis, and 18 patients with other Gram-negative infections. Overall, 86% of the patients were clinically cured or improved. Bacteriological eradication or marked reduction in the number of organisms was achieved in 95% of the patients. In 10 cases of enteric fever and 2 cases of salmonellosis all bacterial pathogens were eradicated, but 1 case of Salmonella paratyphi infection failed clinically. Eleven of 12 biliary tract infections were clinically cured or improved, and organisms were eliminated from all 10 bacteriologically assessable patients. The majority of patients received 1 to 2g of temocillin given by intravenous infusion twice daily for 5 to 14 days. Temocillin was well tolerated by all patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3928321     DOI: 10.2165/00003495-198500295-00044

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  6 in total

1.  Chloramphenicol-resistant typhoid fever in Vietnam associated with R factor.

Authors:  T Butler; N N Linh; K Arnold; M Pollack
Journal:  Lancet       Date:  1973-11-03       Impact factor: 79.321

2.  Antibiotic resistance in typhoid fever. Chloramphenicol resistance among clinical isolates of Salmonella typhosa in Los Angeles, 1972--epidemiologic and bacteriologic characteristics.

Authors:  G Overturf; K I Marton; A W Mathies
Journal:  N Engl J Med       Date:  1973-08-30       Impact factor: 91.245

3.  Temocillin bile levels.

Authors:  M Uwaydah; F Najjar; S Vartivarian; H Harakeh
Journal:  J Antimicrob Chemother       Date:  1984-08       Impact factor: 5.790

4.  Comparative trial of amoxycillin and chloramphenicol in treatment of typhoid fever in adults.

Authors:  N Pillay; E B Adams; D North-Coombes
Journal:  Lancet       Date:  1975-08-23       Impact factor: 79.321

5.  BRL 17421, a novel beta-lactam antibiotic, highly resistant to beta-lactamases, giving high and prolonged serum levels in humans.

Authors:  B Slocombe; M J Basker; P H Bentley; J P Clayton; M Cole; K R Comber; R A Dixon; R A Edmondson; D Jackson; D J Merrikin; R Sutherland
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

6.  Chloramphenicol resistance in the typhoid bacillus.

Authors:  E S Anderson; H R Smith
Journal:  Br Med J       Date:  1972-08-05
  6 in total
  2 in total

1.  In vitro activity of sparfloxacin against selected gram-negative blood culture isolates.

Authors:  Y Siristonpun; V Rojnpisarnvong; A Chongchitmate; S Srimuang; D Tanphaichitra
Journal:  Drugs       Date:  1995       Impact factor: 9.546

2.  Ofloxacin, a new quinolone in the treatment of genitourinary and enteric infections.

Authors:  D Tanphaichitra; S Sahaphong; S Srimuang
Journal:  Infection       Date:  1986       Impact factor: 3.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.